Σεπ162015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα16 Σεπτεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.ΕπόμενοNext post:Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Σχετικά ΆρθραRisk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026Prognostic significance of mild ascites in patients with cirrhosis14 Απριλίου 2026The Rise of Transplant Oncology in Primary Liver Cancer and Metastatic Disease10 Μαρτίου 2026Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program3 Μαρτίου 2026Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis27 Φεβρουαρίου 2026Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation18 Φεβρουαρίου 2026
Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program3 Μαρτίου 2026
Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis27 Φεβρουαρίου 2026
Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation18 Φεβρουαρίου 2026
